Vivos Therapeutics, Inc. · NASDAQ:VVOS

Armistice Capital, LLC reported a 8.27% stake in Vivos Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Armistice Capital, LLC reported a 8.27% stake in Vivos Therapeutics, Inc., 1,115,859 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
8.27%
Shares
1,115,859
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC8.27%1,115,859
Steven Boyd8.27%1,115,859

Source

View original at SEC

Related